GlassScriptPhysician profile
Veronica A Supkay
NPI 1477531978
$3,746.17
in general payments reported to CMS, 2019-2025
33 companies · $1,247 in 2025
The $1,247 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $83.45 · 2021: $39.82 · 2022: $65.12 · 2023: $1,011 · 2024: $1,157 · 2025: $1,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,415.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $484.15 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $417.10 | 2023-2025 | Ubrelvy, Qulipta |
| Otsuka America Pharmaceutical, INC. | $322.32 | 2023-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $277.06 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $225.02 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $223.18 | 2019-2021 | |
| Astellas Pharma US INC | $217.84 | 2023-2024 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $181.43 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Corium, LLC | $164.97 | 2023-2025 | Azstarys |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.34 | 2023-2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Pfizer INC. | $111.85 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $106.30 | 2024-2025 | Zoryve |
| Hologic Sales and Service, LLC | $88.05 | 2025 | Aptima |
| Exact Sciences Corporation | $71.12 | 2023-2025 | Cologuard Collection Kit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53.43 | 2024 | Proclaim, Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $52.83 | 2023-2025 | Inspire |
| Idorsia Pharmaceuticals US INC | $52.65 | 2023-2024 | Quviviq |
| Antares Pharma, INC. | $40.96 | 2023 | Tlando, Xyosted, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $38.19 | 2025 | |
| Sanofi Pasteur INC. | $37.40 | 2023 | |
| Amgen INC. | $37.38 | 2024-2025 | Repatha, Otezla, Repatha |
| Medtronic, INC. | $34.04 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $30.61 | 2024-2025 | Gardasil 9, Capvaxive, Varivax |
| Currax Pharmaceuticals LLC | $30.59 | 2023 | Onzetra Xsail, Contrave |
| Itamar Medical INC | $25.54 | 2023 | Watchpatone |
| Vertiflex, INC. | $23.22 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.13 | 2024 | Crysvita |
| Tris Pharma INC | $20.30 | 2023 | Dyanavel Xr |
| Cranial Technologies, INC | $18.99 | 2023 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $18.89 | 2023 | Trintellix |
| Alk-Abello, INC | $16.96 | 2023 | Odactra, Grastek, Ragwitek |
| Collegium Pharmaceutical, INC. | $14.33 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Supkay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.